Allison Cuff-Shimooka serves as the Chief Operating Officer of TransCelerate BioPharma Inc. In this role, Allison is responsible for translating TransCelerate’s strategic vision into operational plans in close partnership with the leadership team, Member Companies, and Board of Directors. She is also responsible for advancing TransCelerate’s engagement strategy.
Prior to TransCelerate, Allison was the SVP of Strategy and Product Innovation for Optum Life Sciences and oversaw the expansion beyond real world data and evidence generation, into adjacent areas such as clinical trial enablement. She has led the build out of a network of EMR-connected clinical trial sites, launched a protocol design feasibility and patient finding platform, and worked to develop EMR-enabled data management capabilities. Allison received her MBA in health care management from the Wharton School of Business at the University of Pennsylvania. She received her undergraduate degree in chemistry cum laude from Dartmouth College.
Modern trial designs, digital solutions and a deeper understanding of patient realities are helping to open research to more people, including women and others who have historically been underrepresented.